10 Apr 2008 Jerini Ophthalmic signs an exclusive licensing and development agreement with PR Pharmaceuticals to develop sustained-release formulations, including JSM 6427 for the treatment of age-related macular degeneration 07 Dec 2007 Jerini Ophthalmic enters into a research collaboration agreement with...